Nicotinamide Riboside: What It Actually Does to Your NAD+ Levels

A closer look at the vitamin B3 relative that reliably raises NAD+, and what that does and doesn't mean for your health.

Track the foods that fit your goals. Track it free with Ration →

By the Ration Editorial Team · Reviewed against primary research · Updated July 14, 2026

Nicotinamide riboside is a naturally occurring form of vitamin B3, found in small amounts in milk and other foods.

Its main claim to fame is as a precursor to NAD+, short for nicotinamide adenine dinucleotide.

NAD+ is a coenzyme that every cell in your body relies on for energy metabolism, DNA repair, and signaling. Levels of NAD+ naturally decline with age, which is part of why NR and related compounds like nicotinamide mononucleotide (NMN) have drawn so much research interest^[2].

Once ingested, NR is absorbed and converted through a salvage pathway into NAD+, largely bypassing steps that other B3 forms like nicotinamide or niacin require.

Recent research suggests this process also involves enterohepatic circulation, meaning NR and NMN are processed by the gut and liver in a cycle that helps sustain NAD+ synthesis over time^[1].

Animal research first demonstrated that NR supplementation could boost NAD+ levels, enhance oxidative metabolism, and protect against diet-induced obesity in mice^[6]. That early work helped set off the wave of human trials that followed.

This is the part of the NR story with the strongest support. Across multiple randomized controlled trials, NR supplementation consistently and measurably raises NAD+ levels in blood and, in at least one study, in aged skeletal muscle^[4][5].

• ↑NAD+AHuman trials

  Research may raise NAD+ · strong agreement · 6 studies

  View 5 studies on PubMed

  • Nicotinamide Riboside Augments the Aged Human Skeletal Muscle NAD(+) Metabolome and Induces Transcriptomic and Anti-inflammatory Signatures (2019)
  • Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD(+) in healthy middle-aged and older adults (2018)
  • Balancing NAD(+) deficits with nicotinamide riboside: therapeutic possibilities and limitations (2022)
  • The NAD(+) precursor nicotinamide riboside enhances oxidative metabolism and protects against high-fat diet-induced obesity (2012)
  • Nicotinamide riboside and nicotinamide mononucleotide facilitate NAD(+) synthesis via enterohepatic circulation (2025)

A trial in healthy middle-aged and older adults found that chronic NR supplementation was well tolerated and produced a clear, dose-related increase in NAD+ metabolome markers^[5].

Another randomized trial in older adults found that NR supplementation increased the NAD+ metabolome in skeletal muscle and triggered anti-inflammatory gene expression changes, though it did not translate into obvious improvements in muscle strength or physical performance over the study period^[4].

Review articles note that while raising NAD+ is now well established, translating that increase into measurable clinical benefits such as improved metabolic health, cognitive function, or lifespan in humans remains an open question with therapeutic possibilities but real limitations^[3].

A broader review of NAD+ precursors describes NR and NMN as promising dietary contributors to health, while emphasizing that most human data so far focuses on biomarkers like NAD+ levels rather than hard clinical outcomes^[2].

• Cow's milk contains trace amounts of nicotinamide riboside naturally
• Nicotinamide riboside supplements, often sold as capsules under brand names like Niagen
• Related NAD+ precursor supplements such as nicotinamide mononucleotide (NMN)
• Standard vitamin B3 sources like niacin and nicotinamide, which raise NAD+ through a different, slower pathway

Dietary intake from food is minimal compared to supplement doses used in research, which is why nearly all the human trial data comes from concentrated NR supplements rather than food sources.

Human trials have generally tested doses in the range of a few hundred to around 1,000 mg per day, taken for periods ranging from several days to a few months^[4][5].

Higher doses in these trials tended to produce larger, dose-dependent increases in NAD+ markers^[5]. There is no established consensus dose for general use, since these were research protocols rather than clinical guidelines.

In the trials conducted so far, NR has been described as well tolerated in healthy middle-aged and older adults, even with sustained daily use^[5].

• Trials have been relatively short-term, generally weeks to a few months, so long-term safety data is limited
• Most study populations have been small, healthy, and middle-aged to older adults, which limits how broadly the findings apply
• Reported side effects in trials have been mild
• No trial in this list reports serious adverse events attributable to NR

Interest in NR mostly centers on aging, since NAD+ levels decline over the lifespan and researchers are testing whether restoring them can preserve metabolic and muscle function^[4].

• People interested in the biology of NAD+ decline and aging research
• Researchers and clinicians tracking NAD+ metabolome biomarkers
• Those already familiar with related compounds like NMN and comparing the two
• Anyone curious about vitamin B3 metabolism beyond standard niacin

NR is not a treatment for any condition, and the human evidence so far speaks to biomarker changes rather than proven clinical benefits.

The evidence that nicotinamide riboside raises NAD+ levels in humans is genuinely strong, backed by multiple randomized trials and a solid mechanistic explanation involving enterohepatic circulation^[1][5].

What remains uncertain is whether that NAD+ boost reliably improves strength, metabolism, or long-term health outcomes, since trials to date have focused more on biomarkers than on those downstream effects^[3][4].